Tesaro, Inc. (Waltham, Massachusetts)

230 articles with Tesaro, Inc. (Waltham, Massachusetts)

• Tesaro Wins Awards For Clinical Development Team Of The Year And Clinical Partnership Of The Year

  4/7/2017

• FDA Clears Massachusetts Biotech Tesaro's Ovarian Cancer PARP Inhibitor

  3/29/2017

• Tesaro Announces Expanded Development Program For Niraparib Focused On The Treatment Of Front-Line Metastatic Ovarian And Lung Cancers And Metastatic Breast Cancer

  3/28/2017

• AstraZeneca PLC Steals Tesaro's PARP Thunder With Phase III Ovarian Cancer Data

  3/16/2017

• Tesaro Announces Niraparib Data Presentations At The 2017 SGO Annual Meeting On Women's Cancer

  3/13/2017

• Tesaro Announces Fourth-Quarter 2016 Operating Results

  3/1/2017

• Tesaro Receives Positive CHMP Opinion For VARUBY

  2/27/2017

• Sought-After Tesaro Sees A $5 Billion Opportunity For Its Cancer Drug

  2/17/2017

• Tesaro To Announce Fourth-Quarter 2016 Financial Results On February 28, 2017

  2/15/2017

• Tesaro Announces Participation At Two Investor Conferences

  2/3/2017

• Tesaro Biotech Announces Opening Of Niraparib Expanded Access Program For U.S. Patients With Ovarian Cancer

  1/17/2017

• Tesaro Craters as the FDA Denies Approval of Rolapitant IV

  1/13/2017

• Tesaro Announces Priority Review Designation For Niraparib NDA

  12/20/2016

• Tesaro Announces Participation In Three Investor Conferences

  11/22/2016

• With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro and Sarepta

  11/15/2016

• Tesaro Announces Proposed Public Offering Of Common Stock

  11/14/2016

• Tesaro Announces Third-Quarter 2016 Operating Results

  11/4/2016

• Tesaro Announces Submission Of Niraparib New Drug Application For Platinum-Sensitive, Recurrent Ovarian Cancer

  11/2/2016

• Tesaro Announces Presentation Of Niraparib Data At The 2016 IGCS Biennial Meeting

  10/31/2016

• Tesaro Announces Acceptance For Review Of Niraparib Marketing Authorization Application By EMA

  10/28/2016